Related Experiment Video

Updated: Mar 2, 2026

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
09:57

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Published on: March 5, 2018

30.8K

Minimal Residual Disease Negativity Is a New End Point of Myeloma Therapy

Jean-Luc Harousseau1, Herve Avet-Loiseau1

  • 1Jean-Luc Harousseau, Groupe Confluent, Nantes, France; and Herve Avet-Loiseau, Institut Universitaire du Cancer Oncopole, Toulouse, France.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|May 20, 2017
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

776
Modeling Chemotherapy Resistant Leukemia In Vitro08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.6K

Related Concept Videos